Vivanza Biosciences Limited Announces Trading Window Closure
Ahmedabad, India – March 23, 2026 – Vivanza Biosciences Limited (BSE Scrip Code: 530057, ISIN: INE984E01035) announced the closure of its trading window for designated individuals, including promoters, members of the promoter group, directors, key managerial personnel, insiders, and their immediate relatives. The trading window closure is effective from April 1, 2026, and will remain in effect until 48 hours after the public announcement of the company’s standalone and consolidated financial results for the quarter and year ended March 31, 2026.This action is in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and related circulars. During this period, designated individuals are prohibited from engaging in any transactions involving the company's securities.
The date for the upcoming board meeting to formally announce the financial results will be disclosed at a later time.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.